mong the vascular-related diseases in Japanese, cerebrovascular diseases have demonstrated a constant decline, 1,2 partly because of the decrease in sodium intake 3 and the resultant decrease in blood pressure. 4 However, cardiovascular diseases in Japanese have not decreased substantially over several decades, 5 so they are of relatively greater clinical concern. In general, interventional cardiology has progressed rapidly over the past decades, 6, 7 and ample scientific evidence with regard to the appropriate medication to be administered in various situations has also accumulated. This evidence has been generated through a number of clinical researches, and many clinical guidelines are based on these studies; however, there are insufficient reports regarding the actual practice of cardiovascular medicine in Japan, which prompted us to conduct a largescale observational study with patients suffering from significant coronary artery disease (CAD, Japanese coronary Circulation Journal Vol.72, September 2008 artery disease (JCAD) study). 8 The JCAD study has 2 arms: a follow-up arm and a trend-only arm. We previously reported the results of the follow-up arm, in which patients were followed-up for a mean of 2.7 years. 9 In order to elucidate the changes in medication or interventional procedures in Japanese cardiology practice, as well as the angiographic findings in JCAD patients, we analyzed the data of the trend-only group, together with that of the follow-up group, at the time of registration.
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Methods

Patients
The protocol of this study has been published elsewhere. 8 Briefly, consecutive patients who underwent coronary angiography (CAG) and who were diagnosed as having 75% or higher stenosis, based on the classification of the American Heart Association (AHA), 10 in at least 1 branch of a coronary artery were registered for the study. All CAG were performed after obtaining written informed consent from the patients. Patients in the first cohort were enrolled from April 2000 until March 2001. Initially, 15,628 patients were registered and 13,812 of them were followed up. Subsequently, consecutive patients were enrolled every 6 months over 5 periods until September 2003; 22,486 patients were registered with complete initial data, and 18,641 of them were followed up. 
Data Registration and Accumulation
All data were registered electronically as described previously. 8, 11 Briefly, a central database server was set up and the clinical information was transmitted to a central computer through a Web-based interface. Diagnosis of CAD at the time of registration was made by the attending physician based on the information provided in a manual that was distributed prior to the start of the study. The trade names and dosages of all the drugs that the patients were taking were registered by the attending physician. Medication data at the time of discharge was considered in the present analysis. The definition of each risk factor was as follows: hyperlipidemia = serum total cholesterol ≥220 mg/dl and/or low-density lipoprotein-cholesterol ≥140 mg/dl and/or triglyceride ≥150 mg/dl; impaired glucose tolerance (IGT), including diabetes mellitus = fasting blood glucose ≥110 mg/dl; hypertension = systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg; obesity = body mass index ≥25 kg/m 2 ; smoking = at least one episode of smoking in the 2 years before registration; familial history = CAD in any first-degree relative. These data were obtained from each patient by the attending physician. Careful attention was paid to data security.
Angiographic Findings
According to the AHA classification, coronary arteries were classified into 15 segments. When at least 1 segment of an artery (right coronary artery: segments #1-#4; left main trunk (LMT): segment #5; left anterior descending artery (LAD): segments #6-#10; and left circumflex artery: segments #11-#15) had 75% or more stenosis or occlusion, it was classified as diseased. Data were analyzed only for patients with no history of interventional procedures, because previously corrected arteries that did not demonstrate significant restenosis were not registered as diseased. These patients were termed 'de novo' patients.
Investigations
The endpoint was a composite of all-cause death and cardiovascular events and was defined as the occurrence of fatal or nonfatal myocardial infarction (MI), fatal or nonfatal strokes, other cardiovascular events, and death from any cause as the first event. All events were evaluated and registered by the attending physicians. Percutaneous coronary intervention performed against restenosis without clinical symptoms was explicitly excluded as an event.
Ethical Considerations
The institutional review board of each participating institution reviewed and approved the study protocol and other documents. Further, each attending physician explained the study to each candidate patient, who provided voluntary written informed consent prior to enrollment.
Statistical Analysis
Absolute numbers and percentages were computed to describe the patient population. The Kruskal-Wallis test was used to analyze the differences among cohorts with regard to continuous numbers. The Cochran-Armitage test was used to analyze trends over time. P values <0.05 were considered significant. All p values were the result of 2-tailed tests. Statistical analysis was performed using SAS version 9.1 (SAS Institute Inc, Cary, NC, USA).
Results
Background Characteristics
The background characteristics of the patients are shown in Table 1 . Statistically significant increasing trends were observed for the risk factors hyperlipidemia, IGT, hypertension, and obesity. Significant decreasing trends were observed for old MI (OMI), smoking habit, and family history of CAD. Table 2 shows the trend in the angiographic findings for patients without prior coronary intervention. No trend of increase or decrease was observed with regard to the site of stenosis or occlusion in the coronary arteries. When examining for single-vessel disease, the LAD artery was the most frequently detected as diseased; 59.4% of the total de novo patients in this study cohort had a diseased LAD (Table 3) . LMT involvement was calculated to be 7.6% (n=755). 
Angiographic Findings
Choice of Treatment
Trends in the choice of treatment for the affected arteries in the whole cohort are shown in Table 4 . Patients who underwent no interventional procedures were considered to be medically controlled. Plain old balloon angioplasty (POBA) denotes that no interventional procedure other than balloon angioplasty was performed. Statistically significant increasing trends were observed for the use of directional coronary atherectomy and stents. Significant decreasing trends were observed in medical control, POBA, intracoronary thrombolysis (ICT), and intravenous coronary throm- bolysis (IVCT). Trends in the choice of treatment for the affected arteries in the acute MI (AMI) cohort are shown in Table 5 . Statistically significant increasing trends were observed for the use of stents. Significant decreasing trends were observed in medical control, POBA, ICT, and IVCT.
Prescription Trends
The prescription trends at the time of discharge in each group are shown in Table 6 . Statistically significant increasing trends were observed for angiotensin-receptor blockers (ARBs), statins, --blockers, antithrombotics, and diuretics. Significant decreasing trends were observed for angiotensin-converting enzyme inhibitors (ACEI), calcium-channel blockers (CCB), -blockers, fibrates, and nitrates.
Incidence Rate of Events
The incidence rates of events from trend periods 2-5 are shown in Table 7 . Mean follow-up of the patients in the trend-only cohort was 184.1 days. The incidence rate of cerebrocardiovascular events, including all-cause deaths, ranged from 110.2 to 143.0 events per 1,000 patients each year. No trend of decrease or increase in events was observed.
Discussion
In this study, we show for the first time the demographics and changes in medical and interventional treatment of JCAD patients in a large cohort over a 3.5-year period.
It is not known, particularly in Japan, which medicines or interventional procedures are used in actual practice and how they are changing according to the evidence provided by clinical studies. Further, the angiographic findings in the JCAD patients have not been reported for a large cohort, which prompted us to conduct a study in which trends in the JCAD patients were followed for approximately 3.5 years. We followed a total of 36,298 patients in 6 periods. For the first cohort of 15,682 patients, 13,812 of them were followed for a mean of 2.7 years. The remaining 5 cohorts were followed for shorter terms, primarily for the purpose of investigating trends in the modes of treatment and angiographic findings. The results will be discussed below.
Although the absolute changes were not very large, statistically significant increasing trends were observed for hyperlipidemia, IGT, hypertension and obesity (Table 1) . These changes suggest that either people affected with these conditions are increasing in the general population or that people are better controlled medically before they present with symptoms requiring cardiac catheterization. Direct evidence that might have contributed to these results was not available from our data. However, it is plausible that each factor played a role in these trends. Obesity is reported to have increased, particularly in Japanese men, 12 and a significant increase in the prevalence of hypercholesterolemia over a 10-year period has been reported. 13 The prevalence of diabetes mellitus is also increasing in the general Japanese population, 14 whereas hypertension is reported to be declining, 4 because of the decreased sodium chloride intake. 3 However, an increasing trend of hypertension was observed among the patients enrolled in this study, despite the decline in the general population and the awareness regarding the Japanese hypertension guidelines among physicians and their improved adherence to them. 15 Statistically decreasing trends were observed for OMI, family history of CAD, and smoking; the decline in smoking is in agreement with reports concerning the general population. 13 The angiographic findings in patients without prior interventional procedures showed that, when examining for single-vessel disease, LAD involvement was the most frequent (Table 3) , possibly because the LAD is most often the dominant artery and so stenosis will typically cause clinical symptoms. Only 7.6% of the patients had LMT involvement. These findings showed similar traits with previous reports. 16, 17 There were no statistically increasing or decreasing trends in any of the angiographic patterns, which suggests that the angiographic findings observed in this study may represent those of CAD patients in general.
The trend data for the choice of treatment of the diseased arteries (Tables 4,5) show that there was a significant increasing trend in stent use in both the whole cohort and in the AMI subgroup, which may be considered to reflect the evolution of interventional procedures in general. 7 Regarding prescription trends, the most notable trends were the substantial increase in the use of ARBs and the decline in the use of nitrates. The increase in the use of ARBs might be a reflection of the positive results reported during the period of this study. [18] [19] [20] The gradual decrease in the use of CCBs and ACEIs might be because they are being substituted with ARBs. The decrease in the use of nitrates is thought to be the result of a guideline published in 2000 that contraindicated the long-term use of nitrates in stable patients after MI; 21 however, the evidence used to compile that guideline is not the results of randomized control studies. The most commonly prescribed --blocker was carvedilol (data not shown), the increase in the use of which might be related to the publication of several clinical trials of this drug prior to or during the period of this study. 22, 23 Taken together, it might be concluded that doctors participating in the JCAD study modified their practice fairly rapidly to comply with the published evidence.
Event rates for the trend-follow cohort were higher than we had previously reported for the follow-up cohort (Table 7) . Events were also clustered in the first 6 months in the follow-up cohort (data not shown), which suggests that secondary events after acute coronary syndromes tend to concentrate in the early period after interventional procedures. No trend of increase or decrease was observed in the event rates despite significant changes in both medical treatment and interventional procedures. The pattern of the incidence rate of AMI and CHF may have reflected seasonal changes, 24 although the data were insufficient to estimate the reasons for the trends in other events.
In conclusion, changes in the background characteristics of patients who underwent cardiac catheterization reflected the trend observed in the general population, except in the case of hypertension. Angiographic findings did not differ greatly from those reported previously in Western populations, and no increasing or decreasing trends were observed. Stent use increased in both the whole cohort and the AMI subgroup. The fairly rapid change in prescription patterns appeared to reflect the results of published evidence and may imply good compliance of the physicians who participated in this study in this regard. However, these changes were not related to the trend in incidence rates of events observed within 6 months after angiography. Although this study used data from a fairly short period, it may be considered to represent cardiovascular practices of Japanese cardiologists fairly well.
Although careful attention should be paid in interpreting the results, because the background of each cohort might have been heterogeneous, the rapid alteration in actual practices observed in this study suggests the need for continuous investigations in the future.
Study Limitations
It must be noted that this was an observational study and is descriptive in nature. Therefore, most of the reasoning as regards the cause of the results is speculative. For example, regarding the reasons for the change in medication and interventions, we did not perform a questionnaire asking physicians for the reason why they opted for the modes of treatment they had chosen.
It should also be noted that the background of the patients in each cohort might have differed significantly, resulting in different treatment strategy among the cohorts.
The results and conclusions must be interpreted carefully with these backgrounds in mind.
